-
Victoria's Secret, Inovio Pharmaceuticals, Broadcom, Aptorum Group, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Wednesday, March 6, 2024 - 10:18pm | 681Read More...On Wednesday, U.S. indices closed positively as the Dow Jones Industrial Average edged up by 0.2% to reach 38,661.05. Meanwhile, the S&P 500 experienced a slight rise of 0.5%, settling at 5,104.76, whereas the Nasdaq rose by 0.6% to hit 16,031.54. These are the top stocks that gained the...
-
Benzinga's Bulls And Bears Of The Week: Amazon, Citigroup, Facebook, GameStop, Intel And More
Sunday, March 28, 2021 - 7:31am | 1345Read More...Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included e-commerce, social media and banking leaders. A struggling retailer and semiconductor giant were among the bearish calls that were seen. Federal Reserve commentary...
-
Emerald Bioscience Creates Unique Path to Prevent Blindness Using Patented Synthetic Cannabinoids
Friday, December 4, 2020 - 11:17pm | 1198Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The rapid innovation and growth in biotechnology is being used to define, validate, and enhance therapeutic outcomes from cannabinoids....
-
Inovio Pharmaceuticals Begins Phase 1 Human Testing Of Its COVID-19 Vaccine
Tuesday, April 7, 2020 - 4:02am | 494Read More...Inovio Pharmaceuticals Inc.’s (NASDAQ: INO) Bill and Melinda Gates Foundation-backed DNA vaccine for the novel coronavirus enters human trials. What Happened Inovio Pharmaceuticals announced that the United States Food and Drug Administration had accepted the New Drug application for INO...
-
FDA Removes Clinical Hold On Inovio Pharma's VGX-3100, Its First Drug To Enter A Pivotal Study
Thursday, June 8, 2017 - 10:56am | 398Read More...Inovio Pharmaceuticals Inc (NASDAQ: INO) announced Thursday morning it has commenced a Phase III clinical program (called REVEAL) to evaluate the efficacy of its DNA-based immunotherapy, VGX-3100, to treat cervical dysplasia caused by human papillomavirus. Inovio's study will assess the efficacy...
-
Inovio Shares Off 4% After EORTC Trial Enrollment Will Not Go Through
Tuesday, March 29, 2016 - 10:39am | 251Read More...Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO) were trading lower by nearly 4 percent Tuesday morning after the company issued a clinical strategy update. Inovio Pharmaceuticals stated that it will take its INO-3112 HPV immunotherapy into human studies in combination with selected immunotherapy...
-
EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4
Friday, January 29, 2016 - 2:38pm | 454Read More...Inovio Pharmaceuticals Inc (NASDAQ: INO) plans to complete its testing of a Zika vaccine in mice and monkeys by the third quarter of this year before moving to a Phase 1 study in Q4, a company spokesperson told Benzinga. The company said it plans to produce between 5,000 and 10,000 doses by Q3...
-
Morning Market Movers Friday, May 23, 2014
Friday, May 23, 2014 - 10:44am | 388Read More...All moves recorded at 10:20 a.m. EST Gainers PRC Therapeutics (NASDAQ: PTCT) - 50 percent Prosensa Holding N.V. (NASDAQ: RNA) - 27 percent Tuniu (NASDAQ: TOUR) - 19 percent Sportman's Warehouse (NASDAQ: SPWH) - 12 percent ZIOPHARM Oncology (NASDAQ: ZIOP) - 10 percent Wave...
-
Market Wrap For January 3: Bernanke Speaks As Fed Chairman For Last Time; Markets Little Moved
Friday, January 3, 2014 - 5:29pm | 1497Read More...Fed Chairman Ben Bernanke took to the podium today in what many consider to be his farewell speech. During his tenure, Bernanke developed the nickname "Helicopter Ben," which is likely to stick with him for some time. Bernanke noted, "The FOMC's decision to modestly reduce the pace of asset...
